Chinese Traditional and Herbal Drugs
|
2025, 56(1): 98-107
Study on change rule of chemical composition and anti-inflammatory activity of Sinomenii Caulis-Paeoniae Radix Alba compatibility in different compatibility ratios
Full
GENG Feifei1, QU Tong2, LI Ning2, CUI Xiaomin2, HU Jing2, HOU Yafang1, CHENG Yinzi3, YE Chenyu3, CHEN Zhiyong2, REN Hui2
Affiliations
1 School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China;
2 Shaanxi Academy of Traditional Chinese Medicine, Xi'an 710003, China;
3 College of Life Science, Northwest University, Xi'an 710069, China
About Author:
国家重点研发计划 (2023YFC3504900); 国家自然科学基金面上项目 (81973419); 陕西省中医药管理局"双链融合"中青年科研创新团队 (2022-SLRH-YQ-003); 陕西省中医药管理局科研项目 (SZY-KJCYC-2025-JC-051)
doi: 10.7501/j.issn.0253-2670.2025.01.011
Outline
Objective To analyze the correlation between the content variation of characteristic components in different ratios of Qingfengteng (Sinomenii Caulis, SC) to Baishao (Paeoniae Radix Alba, PRA) and their anti-inflammatory effects. Methods HPLC was used to establish the fingerprint and characteristic component quantification methods for different ratios of the SC-PRA (1:1, 1:2, 1:3, 2:1, 2:3, 3:1, 3:2), to analyze the differences and correlations of components among the groups. Lipopolysaccharide (LPS)-induced RAW264.7 cell inflammation model was established. The expression levels of inflammatory factors NO, interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) were measured by the Griess method and ELISA to investigate the anti-inflammatory effects of the SC-PRA pair at different ratios. Principal component analysis (PCA) was applied to integrate the characteristic component content with the expression levels of inflammatory factors, to comprehensively evaluate the optimal ratio of the herbal pair from chemical and pharmacological perspectives. Results A total of 20 common peaks were determined in the SC-PRA pair of seven ratios, with seven components identified, namely gallic acid (peak 1), sinomenine (peak 7), catechin (peak 8), magnoflorine (peak 12), paeoniflorin (peak 13), 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (peak 17), and benzoyl paeoniflorin (peak 20). When the ratio of SC-PRA was 1:2 or 1:3, the content of sinomenine and 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose was the highest; when the ratio was 3:1 or 3:2, the content of magnoflorine, gallic acid, benzoyl paeoniflorin, and paeoniflorin was the highest. Cell experiments indicate that the combination of SC-PRA at ratios of 3:2 and 1:3 exhibits favorable anti-inflammatory activity. PCA analysis found that the comprehensive evaluation of the anti-inflammatory effect of SC-PRA was best at a ratio of 3:2. Conclusion The research method is simple and feasible, revealing the correlation between the content variation of characteristic components and the anti-inflammatory effects of SC-PRA at different ratios through chemical component analysis and in vitro activity evaluation, laying a foundation for further quantitative-effect correlation analysis of the herbal pair, and providing a reference for determining the appropriate dosage in clinical practice.
Sinomenii Caulis-Paeoniae Radix Alba
/
combination
/
fingerprint
/
anti-inflammatory effect
/
principal component analysis
/
gallic acid
/
sinomenine
/
catechin
/
magnoflorine
/
paeoniflorin
/
1
/
2
/
3
/
4
/
6-penta-O-galloyl-β-D-glucopyranose
/
benzoyl paeoniflorin
耿飞飞, 曲彤, 李宁, 崔小敏, 胡静, 后亚芳, 陈音孜, 叶晨昱, 陈志永, 任慧.
青风藤-白芍药对不同配伍比例化学成分与抗炎活性变化规律研究.
中草药,
2025
, 56
(1)
: 98
-107
.
DOI: 10.7501/j.issn.0253-2670.2025.01.011
GENG Feifei, QU Tong, LI Ning, CUI Xiaomin, HU Jing, HOU Yafang, CHENG Yinzi, YE Chenyu, CHEN Zhiyong, REN Hui.
Study on change rule of chemical composition and anti-inflammatory activity of Sinomenii Caulis-Paeoniae Radix Alba compatibility in different compatibility ratios[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(1)
: 98
-107
.
DOI: 10.7501/j.issn.0253-2670.2025.01.011
Year 2025 volume 56 Issue 1
41
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.01.011
- Receive Date:2024-08-12
- Online Date:2026-11-12